Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 850-857

  Cragg, M S ^a   Zhang, L ^b   French, R R ^a   Glennie, M J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Antibody immunotherapy; Crosslinking; Monoclonal antibody; Surface IgM; Transmembrane signalling

Indexed keywords

EPITOPE; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER IMMUNOTHERAPY; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; APOPTOSIS; B-LYMPHOCYTES; BINDING SITES, ANTIBODY; BURKITT LYMPHOMA; CELL DIVISION; CELL MEMBRANE; CELL SURVIVAL; CROSS-LINKING REAGENTS; DNA FRAGMENTATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN M; TUMOR CELLS, CULTURED;

EID: 0033064036     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690136     Document Type: Article

References (21)

1. Bonardi MA, French RR, Amlot P, Gromo G, Modena D and Glennie MJ (1993) Delivery of saporin to human B-cell lymphoma using bispecific antibody targeting via CD22 but not CD19, CD37 or immunoglobulin results in efficient killing. Cancer Res 53: 3015-3021
2. De Franco AL, Raveche ES, Asofsky R and Paul WE (1982) Frequency of lymphocytes b responsive to anti-immunoglobulin. J Exp Med 155: 1523-1536
3. Elliot TJ, Glennie MJ, McBride HM and Stevenson GT (1987) Analysis of the interaction of antibodies with immunoglobulin idiotype of neoplastic B lymphocytes; implications for immunotherapy. J Immunol 138: 981-988
4. George J, Penner SJ, Weber J, Berry J, Caflin JL (1993) Influence of membrane Ig receptor density and affinity on B cell signaling by antigen. J Immunol 151: 5955-5965
5. Glennie MJ, Tutt AL and Greenman J (1993) Preparation of multispecific F (ab′), and F(ab′), antibody derivatives. In Tumour Immunobiology, a Practical Approach, Rees RC, Reynolds CW (eds), pp. 225-244. Oxford University Press: Oxford
6. Gold MR, Matsuuchi L, Kelly RB and De Franco AL (1991) Tyrosine phosphorylation of components of the B-cell antigen receptors following receptor crosslinking. Proc Natl Acad Sci USA 88: 3436-3440
7. Grafton G, Goodall M, Gregory CD and Gordon J (1997) Mechanisms of antigen receptor-dependent apoptosis of human B lymphoma cells probed with a panel of 27 monclonal antibodies. Cell Immunol 182: 45-56
8. Gregory CD, Dive C, Henderson S, Smith CA and Williams GT (1991) Activation of EBV latent genes protects human B cells from death by apoptosis. Nature 349: 612-614
9. Gregory CD, Rowe M and Rickinson AB (1990) Different EBV-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71: 1481-1495
10. Hasbold J and Klaus GGB (1990) Anti-immunoglobulin antibodies induce apoptosis in immature B-cell lymphomas. Eur J Immunol 20: 1685-1690
11. Marches R, Racila E, Tucker TF, Picker L, Mongini P, Hsueh R, Vitetta ES, Scheuermann RH and Uhr JW (1995) Tumour dormancy and cell signalling -III: role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells. Therap Immunol 2: 125-136
12. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propridium iodide staining and flow cytometry. J Immunol Methods 139: 271-279
13. Racila E, Schuermann RH, Picker LJ, Yefenof E, Tucker T, Chang W, Marches R, Street NE, Vitetta ES and Uhr JW (1995) Tumor dormancy and signalling, II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J Exp Med 181: 1539-1550
14. Rudich SM, Roux KH, Winchester RJ and Mongini PKA (1988) Anti-IgM B cell mediated signaling - molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance. J Exp Med 168: 247-266
15. Sefton BM and Campbell MA (1991) The role of tyrosine phosphorylation in lymphocyte activation. Ann Rev Cell Biol 7: 257-274
16. Shan, D, Ledbetter JA and Press OW (1998) Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91: 1644-1652
17. Tutt AL, Stevenson GT and Glennie MJ (1991)Trispecific F(ab), derivatives that use cooperative signalling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells. J Immunol 147: 60-69
18. Tutt AL, French RR, Illidge TM, Honeychurch J, McBride H, Penfold C, Fearon DT, Parkhouse ME, Klaus GGB and Glennie MJ (1998) Monoclonal antibody therapy of B-cell lymphoma: signaling activity on tumour cells appears more important than recruitment of effectors. J Immunol (in press)
19. Van Kooten, Galiber L, Seon BK, Garrone P, Liu Y-J and Banchereau J (1997) Cross-linking of antigen receptor via Ig-β (B29, CD79b) can induce both positive and negative signals in CD40 activated human B cells. Clin Exp Immunol 110: 509-515
20. Vuist WMJ, Levy R and Maloney DG (1994) Lymphoma regression induced by monoclonal anti-idiotype antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumour expression of high levels of bcl-2 protein. Blood 83: 899-906
21. Zhang I, French RR, Chan HTC, Cragg MS, Power MJD and Glennie MJ (1995) The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease. Therap Immunol 2: 191-202